New England Journal of Medicine · 1978 · 189 citations · 20 references
MedicineEndocrinologyOncologyEndocrine OncologyMetastasisNeoplasiaCalcitonin PhysiologyHormone-secreting TumorsMalignant NeoplasmsParathyroid CancerParathyroid NeoplasmsThyroid CancerCalcitonin-secreting TumorsFamilial Medullary Thyroid CarcinomaFamilial Thyroid CancerMedullary Thyroid Carcinoma DiagnosisMedullary Thyroid Carcinoma PathologyMetastatic Thyroid Tissue DetectionProvocative Clinical TestsProvocative Dose
To detect familial medullary thyroid carcinoma in a premetastatic stage, we administered tests provocative of calcitonin secretion (infusion of calcium or pentagastrin or both) each year for seven years to members of a pedigree now numbering 107. Since 1970, 21 patients converted from normal to abnormal secretory responses (two separate tests in which calcitonin levels exceeded 0.58 ng per milliliter). Twenty of 21 glands removed showed C-cell hyperplasia, and eight of the 20 also showed foci of carcinoma. As compared to the 12 patients with tumors detected during the first year of screening, all of whom had bilateral carcinoma (seven of 12 with local metastases), later carcinomas were smaller (mean diameter of 0.2 vs. 0.8 cm), were unilateral (in all but two cases) and occurred in younger patients (mean age of 14.9 vs. 36.4 years), and none had detectable metastases.
20
C-Cell Hyperplasia Preceding Medullary Thyroid Carcinoma
Hubert J. Wolfe, Kenneth E. W. Melvin, Sergio J. Cervi-Skinner et al. · New England Journal of Medicine · 1973 · 452 citations
Medicine, Endocrinology, Pathology +17
Immunoassay of Human Calcitonin
Armen H. Tashjian, Barbara G. Howland, Kenneth E. W. Melvin et al. · New England Journal of Medicine · 1970 · 310 citations
Medicine, Endocrinology, Oncology +15
Studies in familial (medullary) thyroid carcinoma.
Melvin Ke, Tashjian Ah, Miller Hh · PubMed · 1972 · 183 citations